These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 10361377)

  • 1. Pathogenesis of ascites and renal salt retention in cirrhosis.
    Palmer BF
    J Investig Med; 1999 May; 47(5):183-202. PubMed ID: 10361377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Refractory ascites: definition, pathogenesis and treatment.
    Laffi G; La Villa G; Pinzani M; Foschi M; Carloni V; Casini Raggi V; Gentilini P
    Ann Ital Med Int; 1993; 8(1):38-46. PubMed ID: 8485009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular, renal, and neurohumoral responses to single large-volume paracentesis in patients with cirrhosis and diuretic-resistant ascites.
    Peltekian KM; Wong F; Liu PP; Logan AG; Sherman M; Blendis LM
    Am J Gastroenterol; 1997 Mar; 92(3):394-9. PubMed ID: 9068457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term renal sodium handling in patients with cirrhosis treated with transjugular intrahepatic portosystemic shunts for refractory ascites.
    Wong W; Liu P; Blendis L; Wong F
    Am J Med; 1999 Mar; 106(3):315-22. PubMed ID: 10190381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary prostaglandin E2 excretion, sodium retention, and diuretic responsiveness in patients with chronic liver disease.
    Rector WG
    Am J Gastroenterol; 1987 Apr; 82(4):347-51. PubMed ID: 3471082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascites: diagnosis and management.
    Hou W; Sanyal AJ
    Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal handling of sodium and water in early chronic liver disease. Evidence for a reduced natriuretic activity of the cirrhotic urinary extracts in rats.
    Naccarato R; Messa P; D'Angelo A; Fabris A; Messa M; Chiaramonte M; Gregolin C; Zanon G
    Gastroenterology; 1981 Aug; 81(2):205-10. PubMed ID: 7239129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of refractory ascites.
    Singhal S; Baikati KK; Jabbour II; Anand S
    Am J Ther; 2012 Mar; 19(2):121-32. PubMed ID: 21192246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Renal and extra-renal mechanisms of sodium and water retention in cirrhosis with ascites].
    Peña JC
    Rev Invest Clin; 1995; 47(1):63-79. PubMed ID: 7777718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of peritoneovenous shunting in unravelling the pathogenesis of ascites in cirrhosis.
    Blendis LM
    Isr J Med Sci; 1986 Feb; 22(2):78-80. PubMed ID: 3512475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.